trial · primary record
BL-M07D1
HER2-positive Breast Cancer
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 985 |
| Primary completion | 2028-12 |
| Primary endpoint | Pathological complete response (pCR) rate |
| Registry ID | NCT06891833 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:52.820Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06891833
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.